| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | peptide lactyltransferase (CoA-dependent) activity | 1.27e-06 | 2 | 23 | 2 | GO:0120300 | |
| GeneOntologyMolecularFunction | histone H3K27 acetyltransferase activity | 1.27e-06 | 2 | 23 | 2 | GO:0044017 | |
| GeneOntologyMolecularFunction | histone H3K18 acetyltransferase activity | 3.80e-06 | 3 | 23 | 2 | GO:0043993 | |
| GeneOntologyMolecularFunction | transcription coactivator activity | 2.09e-05 | 303 | 23 | 5 | GO:0003713 | |
| GeneOntologyMolecularFunction | histone H3K4 monomethyltransferase activity | 3.54e-05 | 8 | 23 | 2 | GO:0140945 | |
| GeneOntologyMolecularFunction | histone H3K4 trimethyltransferase activity | 5.68e-05 | 10 | 23 | 2 | GO:0140999 | |
| GeneOntologyMolecularFunction | p53 binding | 9.24e-05 | 77 | 23 | 3 | GO:0002039 | |
| GeneOntologyMolecularFunction | histone modifying activity | 1.26e-04 | 229 | 23 | 4 | GO:0140993 | |
| GeneOntologyMolecularFunction | SMAD binding | 1.28e-04 | 86 | 23 | 3 | GO:0046332 | |
| GeneOntologyMolecularFunction | histone H3 acetyltransferase activity | 1.32e-04 | 15 | 23 | 2 | GO:0010484 | |
| GeneOntologyMolecularFunction | histone H3K4 methyltransferase activity | 2.38e-04 | 20 | 23 | 2 | GO:0042800 | |
| GeneOntologyMolecularFunction | peroxisome proliferator activated receptor binding | 2.63e-04 | 21 | 23 | 2 | GO:0042975 | |
| GeneOntologyMolecularFunction | transcription coregulator activity | 3.83e-04 | 562 | 23 | 5 | GO:0003712 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | 6.11e-04 | 1356 | 23 | 7 | GO:0060090 | |
| GeneOntologyMolecularFunction | bHLH transcription factor binding | 8.25e-04 | 37 | 23 | 2 | GO:0043425 | |
| GeneOntologyMolecularFunction | chromatin DNA binding | 9.00e-04 | 167 | 23 | 3 | GO:0031490 | |
| GeneOntologyMolecularFunction | histone H3 methyltransferase activity | 1.17e-03 | 44 | 23 | 2 | GO:0140938 | |
| GeneOntologyMolecularFunction | histone acetyltransferase activity | 1.56e-03 | 51 | 23 | 2 | GO:0004402 | |
| GeneOntologyMolecularFunction | acyltransferase activity | 1.63e-03 | 775 | 23 | 5 | GO:0016746 | |
| GeneOntologyMolecularFunction | transcription coactivator binding | 1.75e-03 | 54 | 23 | 2 | GO:0001223 | |
| GeneOntologyMolecularFunction | peptide-lysine-N-acetyltransferase activity | 1.82e-03 | 55 | 23 | 2 | GO:0061733 | |
| GeneOntologyMolecularFunction | peptide N-acetyltransferase activity | 2.16e-03 | 60 | 23 | 2 | GO:0034212 | |
| GeneOntologyMolecularFunction | pre-mRNA binding | 2.45e-03 | 64 | 23 | 2 | GO:0036002 | |
| GeneOntologyMolecularFunction | protein-lysine N-methyltransferase activity | 2.76e-03 | 68 | 23 | 2 | GO:0016279 | |
| GeneOntologyMolecularFunction | lysine N-methyltransferase activity | 2.84e-03 | 69 | 23 | 2 | GO:0016278 | |
| GeneOntologyMolecularFunction | histone methyltransferase activity | 3.01e-03 | 71 | 23 | 2 | GO:0042054 | |
| GeneOntologyMolecularFunction | N-acetyltransferase activity | 3.61e-03 | 78 | 23 | 2 | GO:0008080 | |
| GeneOntologyMolecularFunction | damaged DNA binding | 4.18e-03 | 84 | 23 | 2 | GO:0003684 | |
| GeneOntologyMolecularFunction | N-acyltransferase activity | 6.10e-03 | 102 | 23 | 2 | GO:0016410 | |
| GeneOntologyMolecularFunction | protein methyltransferase activity | 6.21e-03 | 103 | 23 | 2 | GO:0008276 | |
| GeneOntologyMolecularFunction | acetyltransferase activity | 6.33e-03 | 104 | 23 | 2 | GO:0016407 | |
| GeneOntologyMolecularFunction | N-methyltransferase activity | 6.45e-03 | 105 | 23 | 2 | GO:0008170 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | 7.34e-03 | 1099 | 23 | 5 | GO:0008092 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | 9.18e-03 | 1160 | 23 | 5 | GO:0030674 | |
| GeneOntologyMolecularFunction | transcription factor binding | 1.00e-02 | 753 | 23 | 4 | GO:0008134 | |
| GeneOntologyMolecularFunction | transcription coregulator binding | 1.12e-02 | 140 | 23 | 2 | GO:0001221 | |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | 1.17e-02 | 417 | 23 | 3 | GO:0061629 | |
| GeneOntologyMolecularFunction | S-adenosylmethionine-dependent methyltransferase activity | 1.66e-02 | 172 | 23 | 2 | GO:0008757 | |
| GeneOntologyBiologicalProcess | multicellular organism growth | 6.94e-06 | 249 | 23 | 5 | GO:0035264 | |
| GeneOntologyBiologicalProcess | N-terminal peptidyl-lysine acetylation | 7.13e-06 | 4 | 23 | 2 | GO:0018076 | |
| GeneOntologyBiologicalProcess | positive regulation of cellular response to transforming growth factor beta stimulus | 7.74e-06 | 35 | 23 | 3 | GO:1903846 | |
| GeneOntologyBiologicalProcess | positive regulation of transforming growth factor beta receptor signaling pathway | 7.74e-06 | 35 | 23 | 3 | GO:0030511 | |
| GeneOntologyBiologicalProcess | developmental growth | 4.22e-05 | 911 | 23 | 7 | GO:0048589 | |
| GeneOntologyBiologicalProcess | chromatin remodeling | 1.26e-04 | 741 | 23 | 6 | GO:0006338 | |
| GeneOntologyBiologicalProcess | N-terminal protein amino acid acetylation | 1.41e-04 | 16 | 23 | 2 | GO:0006474 | |
| GeneOntologyBiologicalProcess | regulation of cellular response to heat | 1.41e-04 | 16 | 23 | 2 | GO:1900034 | |
| GeneOntologyBiologicalProcess | positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 2.76e-04 | 115 | 23 | 3 | GO:0090100 | |
| GeneOntologyBiologicalProcess | growth | 2.84e-04 | 1235 | 23 | 7 | GO:0040007 | |
| GeneOntologyBiologicalProcess | regulation of cell adhesion molecule production | 2.97e-04 | 23 | 23 | 2 | GO:0060353 | |
| GeneOntologyBiologicalProcess | stimulatory C-type lectin receptor signaling pathway | 2.97e-04 | 23 | 23 | 2 | GO:0002223 | |
| GeneOntologyBiologicalProcess | cellular response to lectin | 2.97e-04 | 23 | 23 | 2 | GO:1990858 | |
| GeneOntologyBiologicalProcess | response to lectin | 2.97e-04 | 23 | 23 | 2 | GO:1990840 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell development | 3.28e-04 | 122 | 23 | 3 | GO:0055013 | |
| GeneOntologyBiologicalProcess | chromatin organization | 3.53e-04 | 896 | 23 | 6 | GO:0006325 | |
| GeneOntologyBiologicalProcess | cell adhesion molecule production | 3.80e-04 | 26 | 23 | 2 | GO:0060352 | |
| GeneOntologyBiologicalProcess | cardiac cell development | 4.13e-04 | 132 | 23 | 3 | GO:0055006 | |
| GeneOntologyBiologicalProcess | peptidyl-lysine acetylation | 4.42e-04 | 28 | 23 | 2 | GO:0018394 | |
| GeneOntologyBiologicalProcess | epigenetic regulation of gene expression | 4.48e-04 | 330 | 23 | 4 | GO:0040029 | |
| GeneOntologyBiologicalProcess | N-terminal protein amino acid modification | 4.74e-04 | 29 | 23 | 2 | GO:0031365 | |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | 6.31e-04 | 999 | 23 | 6 | GO:0071824 | |
| GeneOntologyCellularComponent | MLL3/4 complex | 7.59e-05 | 12 | 23 | 2 | GO:0044666 | |
| HumanPheno | Pilomatrixoma | 6.25e-07 | 9 | 11 | 3 | HP:0030434 | |
| HumanPheno | Natal tooth | 8.37e-07 | 38 | 11 | 4 | HP:0000695 | |
| HumanPheno | Advanced eruption of teeth | 1.83e-06 | 46 | 11 | 4 | HP:0006288 | |
| HumanPheno | Duplication of phalanx of hallux | 2.69e-06 | 14 | 11 | 3 | HP:0010066 | |
| HumanPheno | Duplication of phalanx of toe | 3.36e-06 | 15 | 11 | 3 | HP:0010181 | |
| HumanPheno | Plantar crease between first and second toes | 4.24e-06 | 2 | 11 | 2 | HP:0008107 | |
| HumanPheno | Aortic isthmus hypoplasia | 4.24e-06 | 2 | 11 | 2 | HP:0034227 | |
| HumanPheno | High axial triradius | 4.24e-06 | 2 | 11 | 2 | HP:0001042 | |
| HumanPheno | Premature thelarche | 5.01e-06 | 17 | 11 | 3 | HP:0010314 | |
| HumanPheno | Abnormality of the bladder | 5.51e-06 | 621 | 11 | 8 | HP:0000014 | |
| HumanPheno | Skin appendage neoplasm | 6.01e-06 | 18 | 11 | 3 | HP:0012842 | |
| HumanPheno | Abnormality of the lower urinary tract | 8.98e-06 | 937 | 11 | 9 | HP:0010936 | |
| HumanPheno | Laryngeal cartilage malformation | 1.27e-05 | 3 | 11 | 2 | HP:0008752 | |
| HumanPheno | Phobia | 1.27e-05 | 3 | 11 | 2 | HP:5200232 | |
| HumanPheno | Agoraphobia | 1.27e-05 | 3 | 11 | 2 | HP:0000756 | |
| HumanPheno | Humoral immunodeficiency | 1.27e-05 | 3 | 11 | 2 | HP:0005363 | |
| HumanPheno | Prominent nasal septum | 1.27e-05 | 3 | 11 | 2 | HP:0005322 | |
| HumanPheno | Radial deviation of thumb terminal phalanx | 1.27e-05 | 3 | 11 | 2 | HP:0005895 | |
| HumanPheno | Shawl scrotum | 1.68e-05 | 25 | 11 | 3 | HP:0000049 | |
| HumanPheno | Perimembranous ventricular septal defect | 1.90e-05 | 26 | 11 | 3 | HP:0011682 | |
| HumanPheno | Supernumerary tooth | 2.18e-05 | 85 | 11 | 4 | HP:0011069 | |
| HumanPheno | Trichiasis | 2.54e-05 | 4 | 11 | 2 | HP:0001128 | |
| HumanPheno | Visceral hemangioma | 2.54e-05 | 4 | 11 | 2 | HP:0410266 | |
| HumanPheno | Talon cusp | 2.54e-05 | 4 | 11 | 2 | HP:0011087 | |
| HumanPheno | Widened distal phalanges | 2.54e-05 | 4 | 11 | 2 | HP:0006200 | |
| HumanPheno | Vascular ring | 2.54e-05 | 4 | 11 | 2 | HP:0010775 | |
| HumanPheno | Hepatic hemangioma | 2.54e-05 | 4 | 11 | 2 | HP:0031207 | |
| HumanPheno | Short columella | 2.66e-05 | 29 | 11 | 3 | HP:0002000 | |
| HumanPheno | Preaxial foot polydactyly | 2.95e-05 | 30 | 11 | 3 | HP:0001841 | |
| HumanPheno | Abnormal bladder morphology | 3.46e-05 | 201 | 11 | 5 | HP:0025487 | |
| HumanPheno | Papillary cystadenoma of the epididymis | 4.22e-05 | 5 | 11 | 2 | HP:0009715 | |
| HumanPheno | Supernumerary cusp | 4.22e-05 | 5 | 11 | 2 | HP:0033777 | |
| HumanPheno | Epididymal neoplasm | 4.22e-05 | 5 | 11 | 2 | HP:0030421 | |
| HumanPheno | Abnormality of the distal phalanx of the thumb | 5.15e-05 | 36 | 11 | 3 | HP:0009617 | |
| HumanPheno | Hydrocele testis | 5.15e-05 | 36 | 11 | 3 | HP:0000034 | |
| HumanPheno | Nasolacrimal duct obstruction | 5.15e-05 | 36 | 11 | 3 | HP:0000579 | |
| HumanPheno | Vesicoureteral reflux | 5.48e-05 | 221 | 11 | 5 | HP:0000076 | |
| HumanPheno | Abnormality of the ureter | 5.80e-05 | 383 | 11 | 6 | HP:0000069 | |
| HumanPheno | Large foramen magnum | 6.33e-05 | 6 | 11 | 2 | HP:0002700 | |
| HumanPheno | Abnormality of dental eruption | 8.15e-05 | 240 | 11 | 5 | HP:0006292 | |
| HumanPheno | Bicuspid aortic valve | 8.23e-05 | 119 | 11 | 4 | HP:0001647 | |
| HumanPheno | Abnormal aortic valve cusp morphology | 8.79e-05 | 121 | 11 | 4 | HP:0031567 | |
| HumanPheno | Deviated nasal septum | 8.85e-05 | 7 | 11 | 2 | HP:0004411 | |
| HumanPheno | Abnormal ureter physiology | 8.99e-05 | 245 | 11 | 5 | HP:0025634 | |
| HumanPheno | Hypoplasia of teeth | 1.03e-04 | 126 | 11 | 4 | HP:0000685 | |
| HumanPheno | Abnormal hallux phalanx morphology | 1.08e-04 | 46 | 11 | 3 | HP:0010057 | |
| HumanPheno | Prominent fingertip pads | 1.08e-04 | 46 | 11 | 3 | HP:0001212 | |
| HumanPheno | Postnatal growth retardation | 1.15e-04 | 258 | 11 | 5 | HP:0008897 | |
| HumanPheno | Abnormal esophagus physiology | 1.20e-04 | 933 | 11 | 8 | HP:0025270 | |
| HumanPheno | Chiari type I malformation | 1.23e-04 | 48 | 11 | 3 | HP:0007099 | |
| HumanPheno | Prominent digit pad | 1.23e-04 | 48 | 11 | 3 | HP:0011298 | |
| HumanPheno | Hydronephrosis | 1.29e-04 | 264 | 11 | 5 | HP:0000126 | |
| HumanPheno | Abnormality of the larynx | 1.30e-04 | 666 | 11 | 7 | HP:0001600 | |
| HumanPheno | Hypoplastic left heart | 1.31e-04 | 49 | 11 | 3 | HP:0004383 | |
| HumanPheno | Abnormal lacrimal duct morphology | 1.39e-04 | 50 | 11 | 3 | HP:0011481 | |
| HumanPheno | Abnormal earlobe morphology | 1.43e-04 | 137 | 11 | 4 | HP:0000363 | |
| HumanPheno | Congenital malformation of the left heart | 1.47e-04 | 51 | 11 | 3 | HP:0045017 | |
| HumanPheno | Cervical cord compression | 1.51e-04 | 9 | 11 | 2 | HP:0002341 | |
| HumanPheno | Abnormality of the urethra | 1.74e-04 | 465 | 11 | 6 | HP:0000795 | |
| HumanPheno | Hypoplastic heart | 1.75e-04 | 54 | 11 | 3 | HP:0001961 | |
| HumanPheno | Bilateral cryptorchidism | 1.75e-04 | 54 | 11 | 3 | HP:0008689 | |
| HumanPheno | Panic attack | 1.85e-04 | 55 | 11 | 3 | HP:0025269 | |
| HumanPheno | Frontal hirsutism | 1.89e-04 | 10 | 11 | 2 | HP:0011335 | |
| HumanPheno | Bronchiolitis | 1.89e-04 | 10 | 11 | 2 | HP:0011950 | |
| HumanPheno | Non-epileptic seizure | 1.95e-04 | 56 | 11 | 3 | HP:0033052 | |
| HumanPheno | Low hanging columella | 1.95e-04 | 56 | 11 | 3 | HP:0009765 | |
| HumanPheno | Impulsivity | 1.98e-04 | 149 | 11 | 4 | HP:0100710 | |
| HumanPheno | Dilatation of the renal pelvis | 2.01e-04 | 290 | 11 | 5 | HP:0010946 | |
| HumanPheno | Abnormal subclavian artery morphology | 2.31e-04 | 11 | 11 | 2 | HP:0031251 | |
| HumanPheno | Abnormal renal pelvis morphology | 2.36e-04 | 300 | 11 | 5 | HP:0010944 | |
| HumanPheno | Abnormality of the dentition | 2.50e-04 | 1030 | 11 | 8 | HP:0000164 | |
| HumanPheno | Abnormal stomach morphology | 2.61e-04 | 742 | 11 | 7 | HP:0002577 | |
| HumanPheno | Diagnostic behavioral phenotype | 2.73e-04 | 747 | 11 | 7 | HP:0025783 | |
| HumanPheno | Polyhydramnios | 2.84e-04 | 312 | 11 | 5 | HP:0001561 | |
| HumanPheno | Aggressive behavior | 3.11e-04 | 516 | 11 | 6 | HP:0000718 | |
| HumanPheno | Abnormal aggressive, impulsive or violent behavior | 3.11e-04 | 516 | 11 | 6 | HP:0006919 | |
| HumanPheno | Gastroesophageal reflux | 3.14e-04 | 517 | 11 | 6 | HP:0002020 | |
| HumanPheno | Facial grimacing | 3.26e-04 | 13 | 11 | 2 | HP:0000273 | |
| HumanPheno | Keloids | 3.26e-04 | 13 | 11 | 2 | HP:0010562 | |
| HumanPheno | Eclabion | 3.44e-04 | 172 | 11 | 4 | HP:0012472 | |
| HumanPheno | Abnormality of external features of the abdomen | 3.49e-04 | 326 | 11 | 5 | HP:0001462 | |
| HumanPheno | Abnormal esophagus morphology | 3.50e-04 | 1078 | 11 | 8 | HP:0002031 | |
| HumanPheno | Hyperpigmentation of the skin | 3.59e-04 | 328 | 11 | 5 | HP:0000953 | |
| HumanPheno | Carious teeth | 3.60e-04 | 174 | 11 | 4 | HP:0000670 | |
| HumanPheno | Hypoplastic aortic arch | 3.80e-04 | 14 | 11 | 2 | HP:0012304 | |
| HumanPheno | Parietal foramina | 3.80e-04 | 14 | 11 | 2 | HP:0002697 | |
| HumanPheno | Abnormality of the upper respiratory tract | 4.37e-04 | 1111 | 11 | 8 | HP:0002087 | |
| HumanPheno | Social and occupational deterioration | 4.38e-04 | 15 | 11 | 2 | HP:0007086 | |
| HumanPheno | Reduced circulating growth hormone concentration | 4.38e-04 | 15 | 11 | 2 | HP:0034323 | |
| HumanPheno | Atypical scarring of skin | 4.47e-04 | 74 | 11 | 3 | HP:0000987 | |
| HumanPheno | Smooth philtrum | 4.55e-04 | 185 | 11 | 4 | HP:0000319 | |
| HumanPheno | Precocious puberty | 4.64e-04 | 186 | 11 | 4 | HP:0000826 | |
| HumanPheno | Broad hallux | 4.83e-04 | 76 | 11 | 3 | HP:0010055 | |
| HumanPheno | Early onset of sexual maturation | 4.94e-04 | 189 | 11 | 4 | HP:0100000 | |
| HumanPheno | Square face | 5.00e-04 | 16 | 11 | 2 | HP:0000321 | |
| HumanPheno | Abnormality of calvarial morphology | 5.07e-04 | 1134 | 11 | 8 | HP:0002648 | |
| HumanPheno | Neoplasm of the nervous system | 5.56e-04 | 195 | 11 | 4 | HP:0004375 | |
| HumanPheno | Recurrent acute respiratory tract infection | 5.67e-04 | 17 | 11 | 2 | HP:0011948 | |
| HumanPheno | Abnormal pulmonary valve morphology | 5.89e-04 | 198 | 11 | 4 | HP:0001641 | |
| HumanPheno | Truncal obesity | 6.04e-04 | 82 | 11 | 3 | HP:0001956 | |
| MousePheno | abnormal myocardium compact layer morphology | 1.32e-04 | 67 | 21 | 3 | MP:0004056 | |
| MousePheno | flattened snout | 1.41e-04 | 12 | 21 | 2 | MP:0000447 | |
| MousePheno | abnormal atrioventricular septum morphology | 2.86e-04 | 87 | 21 | 3 | MP:0010592 | |
| MousePheno | abnormal myocardium layer morphology | 3.06e-04 | 414 | 21 | 5 | MP:0005329 | |
| MousePheno | lethality during fetal growth through weaning, complete penetrance | 3.12e-04 | 1269 | 21 | 8 | MP:0011111 | |
| MousePheno | abnormal heart layer morphology | 3.34e-04 | 422 | 21 | 5 | MP:0010545 | |
| MousePheno | thin ventricle myocardium compact layer | 4.02e-04 | 20 | 21 | 2 | MP:0010556 | |
| Domain | - | 1.20e-06 | 2 | 21 | 2 | 1.10.246.20 | |
| Domain | zf-TAZ | 1.20e-06 | 2 | 21 | 2 | PF02135 | |
| Domain | ZF_TAZ | 1.20e-06 | 2 | 21 | 2 | PS50134 | |
| Domain | Nuc_rcpt_coact_CREBbp | 1.20e-06 | 2 | 21 | 2 | IPR014744 | |
| Domain | HAT_KAT11 | 1.20e-06 | 2 | 21 | 2 | PF08214 | |
| Domain | KIX | 1.20e-06 | 2 | 21 | 2 | PS50952 | |
| Domain | ZnF_TAZ | 1.20e-06 | 2 | 21 | 2 | SM00551 | |
| Domain | CBP_P300_HAT | 1.20e-06 | 2 | 21 | 2 | IPR031162 | |
| Domain | Histone_AcTrfase_Rtt109/CBP | 1.20e-06 | 2 | 21 | 2 | IPR013178 | |
| Domain | DUF902 | 1.20e-06 | 2 | 21 | 2 | PF06001 | |
| Domain | - | 1.20e-06 | 2 | 21 | 2 | 1.20.1020.10 | |
| Domain | RING_CBP-p300 | 1.20e-06 | 2 | 21 | 2 | IPR010303 | |
| Domain | KAT11 | 1.20e-06 | 2 | 21 | 2 | SM01250 | |
| Domain | - | 1.20e-06 | 2 | 21 | 2 | 1.10.1630.10 | |
| Domain | Znf_TAZ | 1.20e-06 | 2 | 21 | 2 | IPR000197 | |
| Domain | KIX_dom | 1.20e-06 | 2 | 21 | 2 | IPR003101 | |
| Domain | Creb_binding | 1.20e-06 | 2 | 21 | 2 | PF09030 | |
| Domain | KIX | 1.20e-06 | 2 | 21 | 2 | PF02172 | |
| Domain | CBP_P300_HAT | 1.20e-06 | 2 | 21 | 2 | PS51727 | |
| Domain | FYrich_C | 1.20e-05 | 5 | 21 | 2 | IPR003889 | |
| Domain | FYrich_N | 1.20e-05 | 5 | 21 | 2 | IPR003888 | |
| Domain | FYRC | 1.20e-05 | 5 | 21 | 2 | SM00542 | |
| Domain | FYRN | 1.20e-05 | 5 | 21 | 2 | SM00541 | |
| Domain | FYRN | 1.20e-05 | 5 | 21 | 2 | PF05964 | |
| Domain | FYRC | 1.20e-05 | 5 | 21 | 2 | PF05965 | |
| Domain | FYRC | 1.20e-05 | 5 | 21 | 2 | PS51543 | |
| Domain | FYRN | 1.20e-05 | 5 | 21 | 2 | PS51542 | |
| Domain | Nuc_rcpt_coact | 1.80e-05 | 6 | 21 | 2 | IPR009110 | |
| Domain | Post-SET_dom | 1.43e-04 | 16 | 21 | 2 | IPR003616 | |
| Domain | PostSET | 1.43e-04 | 16 | 21 | 2 | SM00508 | |
| Domain | POST_SET | 1.43e-04 | 16 | 21 | 2 | PS50868 | |
| Domain | ZF_PHD_2 | 1.59e-04 | 95 | 21 | 3 | PS50016 | |
| Domain | ZF_PHD_1 | 1.64e-04 | 96 | 21 | 3 | PS01359 | |
| Domain | ZF_ZZ_2 | 1.82e-04 | 18 | 21 | 2 | PS50135 | |
| Domain | ZF_ZZ_1 | 1.82e-04 | 18 | 21 | 2 | PS01357 | |
| Domain | ZZ | 1.82e-04 | 18 | 21 | 2 | PF00569 | |
| Domain | Znf_ZZ | 2.04e-04 | 19 | 21 | 2 | IPR000433 | |
| Domain | ZnF_ZZ | 2.04e-04 | 19 | 21 | 2 | SM00291 | |
| Domain | EPHD | 2.74e-04 | 22 | 21 | 2 | PS51805 | |
| Domain | Bromodomain_CS | 3.85e-04 | 26 | 21 | 2 | IPR018359 | |
| Domain | HECT | 4.16e-04 | 27 | 21 | 2 | PF00632 | |
| Domain | HECTc | 4.16e-04 | 27 | 21 | 2 | SM00119 | |
| Domain | HECT_dom | 4.16e-04 | 27 | 21 | 2 | IPR000569 | |
| Domain | HECT | 4.16e-04 | 27 | 21 | 2 | PS50237 | |
| Domain | Znf_FYVE_PHD | 5.73e-04 | 147 | 21 | 3 | IPR011011 | |
| Domain | BROMODOMAIN_1 | 7.83e-04 | 37 | 21 | 2 | PS00633 | |
| Domain | Bromodomain | 8.26e-04 | 38 | 21 | 2 | PF00439 | |
| Domain | BROMODOMAIN_2 | 9.62e-04 | 41 | 21 | 2 | PS50014 | |
| Domain | SET | 9.62e-04 | 41 | 21 | 2 | PF00856 | |
| Domain | BROMO | 1.01e-03 | 42 | 21 | 2 | SM00297 | |
| Domain | Bromodomain | 1.01e-03 | 42 | 21 | 2 | IPR001487 | |
| Domain | - | 1.01e-03 | 42 | 21 | 2 | 1.20.920.10 | |
| Domain | SET | 1.21e-03 | 46 | 21 | 2 | SM00317 | |
| Domain | WW | 1.26e-03 | 47 | 21 | 2 | PF00397 | |
| Domain | WW | 1.32e-03 | 48 | 21 | 2 | SM00456 | |
| Domain | SET_dom | 1.43e-03 | 50 | 21 | 2 | IPR001214 | |
| Domain | SET | 1.43e-03 | 50 | 21 | 2 | PS50280 | |
| Domain | WW_DOMAIN_2 | 1.49e-03 | 51 | 21 | 2 | PS50020 | |
| Domain | WW_DOMAIN_1 | 1.49e-03 | 51 | 21 | 2 | PS01159 | |
| Domain | WW_dom | 1.54e-03 | 52 | 21 | 2 | IPR001202 | |
| Domain | HMG_box | 1.60e-03 | 53 | 21 | 2 | PF00505 | |
| Domain | HMG | 1.66e-03 | 54 | 21 | 2 | SM00398 | |
| Domain | HMG_box_dom | 2.40e-03 | 65 | 21 | 2 | IPR009071 | |
| Domain | PHD | 3.18e-03 | 75 | 21 | 2 | PF00628 | |
| Domain | Znf_PHD-finger | 3.52e-03 | 79 | 21 | 2 | IPR019787 | |
| Domain | PHD | 4.45e-03 | 89 | 21 | 2 | SM00249 | |
| Domain | RING | 4.61e-03 | 305 | 21 | 3 | SM00184 | |
| Domain | Znf_PHD | 4.64e-03 | 91 | 21 | 2 | IPR001965 | |
| Domain | Znf_RING | 5.55e-03 | 326 | 21 | 3 | IPR001841 | |
| Pathway | WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA | 9.36e-07 | 65 | 17 | 4 | M39682 | |
| Pathway | REACTOME_ACTIVATION_OF_ANTERIOR_HOX_GENES_IN_HINDBRAIN_DEVELOPMENT_DURING_EARLY_EMBRYOGENESIS | 1.16e-05 | 122 | 17 | 4 | M29689 | |
| Pathway | BIOCARTA_PELP1_PATHWAY | 1.37e-05 | 5 | 17 | 2 | MM1575 | |
| Pathway | REACTOME_NFE2L2_REGULATING_INFLAMMATION_ASSOCIATED_GENES | 1.37e-05 | 5 | 17 | 2 | M48020 | |
| Pathway | REACTOME_LRR_FLII_INTERACTING_PROTEIN_1_LRRFIP1_ACTIVATES_TYPE_I_IFN_PRODUCTION | 1.37e-05 | 5 | 17 | 2 | M27228 | |
| Pathway | REACTOME_NFE2L2_REGULATING_ER_STRESS_ASSOCIATED_GENES | 1.37e-05 | 5 | 17 | 2 | M48023 | |
| Pathway | BIOCARTA_PELP1_PATHWAY | 2.05e-05 | 6 | 17 | 2 | M22062 | |
| Pathway | BIOCARTA_PPARG_PATHWAY | 2.86e-05 | 7 | 17 | 2 | MM1573 | |
| Pathway | BIOCARTA_PPARG_PATHWAY | 3.82e-05 | 8 | 17 | 2 | M22058 | |
| Pathway | REACTOME_NFE2L2_REGULATING_MDR_ASSOCIATED_ENZYMES | 3.82e-05 | 8 | 17 | 2 | M48022 | |
| Pathway | REACTOME_REGULATION_OF_NFE2L2_GENE_EXPRESSION | 3.82e-05 | 8 | 17 | 2 | M48024 | |
| Pathway | REACTOME_NFE2L2_REGULATES_PENTOSE_PHOSPHATE_PATHWAY_GENES | 3.82e-05 | 8 | 17 | 2 | M46443 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TLR3_IRF3_SIGNALING_PATHWAY | 4.90e-05 | 9 | 17 | 2 | M47451 | |
| Pathway | REACTOME_REGULATION_OF_FOXO_TRANSCRIPTIONAL_ACTIVITY_BY_ACETYLATION | 6.12e-05 | 10 | 17 | 2 | M27945 | |
| Pathway | BIOCARTA_CARM1_PATHWAY | 7.48e-05 | 11 | 17 | 2 | MM1521 | |
| Pathway | REACTOME_NFE2L2_REGULATING_TUMORIGENIC_GENES | 7.48e-05 | 11 | 17 | 2 | M48021 | |
| Pathway | REACTOME_REGULATION_OF_GENE_EXPRESSION_BY_HYPOXIA_INDUCIBLE_FACTOR | 7.48e-05 | 11 | 17 | 2 | M26924 | |
| Pathway | BIOCARTA_CARM1_PATHWAY | 8.97e-05 | 12 | 17 | 2 | M7968 | |
| Pathway | REACTOME_ACTIVATION_OF_THE_TFAP2_AP_2_FAMILY_OF_TRANSCRIPTION_FACTORS | 8.97e-05 | 12 | 17 | 2 | M27765 | |
| Pathway | REACTOME_RUNX3_REGULATES_NOTCH_SIGNALING | 1.24e-04 | 14 | 17 | 2 | M27808 | |
| Pathway | BIOCARTA_RELA_PATHWAY | 1.42e-04 | 15 | 17 | 2 | MM1339 | |
| Pathway | BIOCARTA_RELA_PATHWAY | 1.42e-04 | 15 | 17 | 2 | M10183 | |
| Pathway | BIOCARTA_PITX2_PATHWAY | 1.42e-04 | 15 | 17 | 2 | MM1439 | |
| Pathway | REACTOME_TRAF3_DEPENDENT_IRF_ACTIVATION_PATHWAY | 1.42e-04 | 15 | 17 | 2 | M953 | |
| Pathway | REACTOME_TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT | 1.46e-04 | 233 | 17 | 4 | M27099 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX1 | 1.56e-04 | 237 | 17 | 4 | M27786 | |
| Pathway | BIOCARTA_IL7_PATHWAY | 1.63e-04 | 16 | 17 | 2 | M1296 | |
| Pathway | BIOCARTA_IL7_PATHWAY | 1.63e-04 | 16 | 17 | 2 | MM1420 | |
| Pathway | BIOCARTA_PITX2_PATHWAY | 1.63e-04 | 16 | 17 | 2 | M8516 | |
| Pathway | REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_LATE_STAGE_BRANCHING_MORPHOGENESIS_PANCREATIC_BUD_PRECURSOR_CELLS | 1.63e-04 | 16 | 17 | 2 | M27121 | |
| Pathway | REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_CELL_DEATH_GENES | 1.63e-04 | 16 | 17 | 2 | M27940 | |
| Pathway | REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX | 1.66e-04 | 91 | 17 | 3 | M27101 | |
| Pathway | BIOCARTA_TGFB_PATHWAY | 1.84e-04 | 17 | 17 | 2 | MM1509 | |
| Pathway | REACTOME_ZYGOTIC_GENOME_ACTIVATION_ZGA | 1.84e-04 | 17 | 17 | 2 | M48025 | |
| Pathway | REACTOME_RUNX1_REGULATES_GENES_INVOLVED_IN_MEGAKARYOCYTE_DIFFERENTIATION_AND_PLATELET_FUNCTION | 1.94e-04 | 96 | 17 | 3 | M27792 | |
| Pathway | REACTOME_RORA_ACTIVATES_GENE_EXPRESSION | 2.07e-04 | 18 | 17 | 2 | M26942 | |
| Pathway | BIOCARTA_TGFB_PATHWAY | 2.31e-04 | 19 | 17 | 2 | M18933 | |
| Pathway | REACTOME_NFE2L2_REGULATING_ANTI_OXIDANT_DETOXIFICATION_ENZYMES | 2.31e-04 | 19 | 17 | 2 | M46442 | |
| Pathway | REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_CYTOCHROME_C_RELEASE | 2.57e-04 | 20 | 17 | 2 | M27628 | |
| Pathway | REACTOME_NOTCH4_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 2.57e-04 | 20 | 17 | 2 | M27881 | |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | 2.65e-04 | 272 | 17 | 4 | M29619 | |
| Pathway | WP_HEMATOPOIETIC_STEM_CELL_GENE_REGULATION_BY_GABP_ALPHABETA_COMPLEX | 2.84e-04 | 21 | 17 | 2 | M39593 | |
| Pathway | REACTOME_CD209_DC_SIGN_SIGNALING | 2.84e-04 | 21 | 17 | 2 | M27485 | |
| Pathway | BIOCARTA_NTHI_PATHWAY | 3.12e-04 | 22 | 17 | 2 | MM1443 | |
| Pathway | BIOCARTA_VDR_PATHWAY | 3.12e-04 | 22 | 17 | 2 | MM1370 | |
| Pathway | BIOCARTA_NTHI_PATHWAY | 3.41e-04 | 23 | 17 | 2 | M2821 | |
| Pathway | BIOCARTA_VDR_PATHWAY | 3.72e-04 | 24 | 17 | 2 | M13404 | |
| Pathway | WP_MECHANISMS_ASSOCIATED_WITH_PLURIPOTENCY | 3.89e-04 | 301 | 17 | 4 | MM15983 | |
| Pathway | REACTOME_NOTCH3_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 4.04e-04 | 25 | 17 | 2 | M27880 | |
| Pathway | BIOCARTA_CARM_ER_PATHWAY | 4.37e-04 | 26 | 17 | 2 | M2499 | |
| Pathway | PID_HDAC_CLASSIII_PATHWAY | 4.37e-04 | 26 | 17 | 2 | M32 | |
| Pathway | REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX | 4.37e-04 | 26 | 17 | 2 | MM14793 | |
| Pathway | REACTOME_ATTENUATION_PHASE | 5.08e-04 | 28 | 17 | 2 | M27254 | |
| Pathway | REACTOME_SIGNALING_BY_WNT | 5.51e-04 | 330 | 17 | 4 | M7847 | |
| Pathway | PID_P53_DOWNSTREAM_PATHWAY | 5.53e-04 | 137 | 17 | 3 | M145 | |
| Pathway | PID_RETINOIC_ACID_PATHWAY | 5.84e-04 | 30 | 17 | 2 | M207 | |
| Pathway | REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION | 5.84e-04 | 30 | 17 | 2 | M936 | |
| Pathway | WP_INITIATION_OF_TRANSCRIPTION_AND_TRANSLATION_ELONGATION_AT_THE_HIV1_LTR | 6.65e-04 | 32 | 17 | 2 | M39521 | |
| Pathway | WP_TYPE_2_PAPILLARY_RENAL_CELL_CARCINOMA | 7.51e-04 | 34 | 17 | 2 | M39771 | |
| Pathway | PID_HIF2PATHWAY | 7.51e-04 | 34 | 17 | 2 | M44 | |
| Pathway | REACTOME_EVASION_BY_RSV_OF_HOST_INTERFERON_RESPONSES | 7.96e-04 | 35 | 17 | 2 | M48246 | |
| Pathway | REACTOME_TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT | 8.37e-04 | 158 | 17 | 3 | MM14791 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_THE_AP_2_TFAP2_FAMILY_OF_TRANSCRIPTION_FACTORS | 9.38e-04 | 38 | 17 | 2 | M27757 | |
| Pathway | REACTOME_HSF1_DEPENDENT_TRANSACTIVATION | 9.38e-04 | 38 | 17 | 2 | M27255 | |
| Pathway | PID_FOXM1_PATHWAY | 1.04e-03 | 40 | 17 | 2 | M176 | |
| Pathway | PID_IFNG_PATHWAY | 1.04e-03 | 40 | 17 | 2 | M161 | |
| Pathway | REACTOME_REGULATION_OF_BETA_CELL_DEVELOPMENT | 1.15e-03 | 42 | 17 | 2 | M17541 | |
| Pathway | REACTOME_FORMATION_OF_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES | 1.15e-03 | 42 | 17 | 2 | M48018 | |
| Pathway | PID_HNF3A_PATHWAY | 1.26e-03 | 44 | 17 | 2 | M285 | |
| Pathway | REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_CELL_DEATH_GENES | 1.26e-03 | 44 | 17 | 2 | M27499 | |
| Pathway | REACTOME_SUMOYLATION_OF_TRANSCRIPTION_COFACTORS | 1.26e-03 | 44 | 17 | 2 | M27295 | |
| Pathway | REACTOME_RUNX1_REGULATES_GENES_INVOLVED_IN_MEGAKARYOCYTE_DIFFERENTIATION_AND_PLATELET_FUNCTION | 1.26e-03 | 44 | 17 | 2 | MM15527 | |
| Pathway | KEGG_NOTCH_SIGNALING_PATHWAY | 1.43e-03 | 47 | 17 | 2 | M7946 | |
| Pathway | PID_HES_HEY_PATHWAY | 1.49e-03 | 48 | 17 | 2 | M288 | |
| Pathway | REACTOME_NOTCH1_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 1.49e-03 | 48 | 17 | 2 | M611 | |
| Pathway | PID_FOXO_PATHWAY | 1.56e-03 | 49 | 17 | 2 | M136 | |
| Pathway | REACTOME_HEME_SIGNALING | 1.56e-03 | 49 | 17 | 2 | M41832 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH3 | 1.56e-03 | 49 | 17 | 2 | M618 | |
| Pathway | BIOCARTA_PPARA_PATHWAY | 1.75e-03 | 52 | 17 | 2 | M2404 | |
| Pathway | PID_NFAT_3PATHWAY | 1.82e-03 | 53 | 17 | 2 | M113 | |
| Pathway | PID_AR_TF_PATHWAY | 1.82e-03 | 53 | 17 | 2 | M151 | |
| Pathway | WP_TGFBETA_SIGNALING_PATHWAY | 1.82e-03 | 53 | 17 | 2 | MM15880 | |
| Pathway | PID_TAP63_PATHWAY | 1.89e-03 | 54 | 17 | 2 | M256 | |
| Pathway | WP_TGFBETA_RECEPTOR_SIGNALING | 1.96e-03 | 55 | 17 | 2 | M39351 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1_PEST_DOMAIN_MUTANTS_IN_CANCER | 2.17e-03 | 58 | 17 | 2 | M29616 | |
| Pathway | WP_TGFBETA_RECEPTOR_SIGNALING_IN_SKELETAL_DYSPLASIAS | 2.25e-03 | 59 | 17 | 2 | M39886 | |
| Pathway | PID_P53_REGULATION_PATHWAY | 2.25e-03 | 59 | 17 | 2 | M261 | |
| Pathway | REACTOME_CYTOSOLIC_SENSORS_OF_PATHOGEN_ASSOCIATED_DNA | 2.64e-03 | 64 | 17 | 2 | M27046 | |
| Pathway | WP_HISTONE_MODIFICATIONS | 2.72e-03 | 65 | 17 | 2 | M39374 | |
| Pathway | PID_RB_1PATHWAY | 2.72e-03 | 65 | 17 | 2 | M279 | |
| Pathway | REACTOME_SIGNALING_BY_WNT | 2.74e-03 | 239 | 17 | 3 | MM14756 | |
| Pathway | PID_HIF1_TFPATHWAY | 2.81e-03 | 66 | 17 | 2 | M255 | |
| Pathway | PID_HDAC_CLASSI_PATHWAY | 2.81e-03 | 66 | 17 | 2 | M101 | |
| Pathway | REACTOME_FOXO_MEDIATED_TRANSCRIPTION | 2.81e-03 | 66 | 17 | 2 | M27938 | |
| Pathway | WP_UROTENSINIIMEDIATED_SIGNALING | 3.06e-03 | 69 | 17 | 2 | M48052 | |
| Pathway | REACTOME_FORMATION_OF_PARAXIAL_MESODERM | 3.06e-03 | 69 | 17 | 2 | M46439 | |
| Pathway | KEGG_LONG_TERM_POTENTIATION | 3.15e-03 | 70 | 17 | 2 | M3115 | |
| Pathway | KEGG_RENAL_CELL_CARCINOMA | 3.15e-03 | 70 | 17 | 2 | M13266 | |
| Pathway | REACTOME_PKMTS_METHYLATE_HISTONE_LYSINES | 3.15e-03 | 70 | 17 | 2 | M27231 | |
| Pathway | REACTOME_CIRCADIAN_CLOCK | 3.15e-03 | 70 | 17 | 2 | M938 | |
| Pubmed | 1.45e-13 | 4 | 23 | 4 | 28398509 | ||
| Pubmed | ATRX PPP1R13B GIGYF2 CREBBP KMT2C EP300 TIMM10B PCM1 KMT2D KIF7 EIF3H | 4.65e-10 | 1429 | 23 | 11 | 35140242 | |
| Pubmed | 4.63e-08 | 549 | 23 | 7 | 38280479 | ||
| Pubmed | 5.61e-08 | 57 | 23 | 4 | 18022353 | ||
| Pubmed | 9.15e-08 | 14 | 23 | 3 | 12482968 | ||
| Pubmed | 4.18e-07 | 2 | 23 | 2 | 27881875 | ||
| Pubmed | 4.18e-07 | 2 | 23 | 2 | 28483418 | ||
| Pubmed | Expression of the nuclear coactivators CBP and p300 in developing craniofacial tissue. | 4.18e-07 | 2 | 23 | 2 | 11963968 | |
| Pubmed | Molecular characterization of the histone acetyltransferase CREBBP/EP300 genes in myeloid neoplasia. | 4.18e-07 | 2 | 23 | 2 | 34845315 | |
| Pubmed | p300 or CBP is required for insulin-stimulated glucose uptake in skeletal muscle and adipocytes. | 4.18e-07 | 2 | 23 | 2 | 34813504 | |
| Pubmed | 4.18e-07 | 2 | 23 | 2 | 19729597 | ||
| Pubmed | 4.18e-07 | 2 | 23 | 2 | 36869380 | ||
| Pubmed | 4.18e-07 | 2 | 23 | 2 | 15860545 | ||
| Pubmed | 4.18e-07 | 2 | 23 | 2 | 9528808 | ||
| Pubmed | Analysis of genetic stability at the EP300 and CREBBP loci in a panel of cancer cell lines. | 4.18e-07 | 2 | 23 | 2 | 12696060 | |
| Pubmed | 4.18e-07 | 2 | 23 | 2 | 29460469 | ||
| Pubmed | 4.18e-07 | 2 | 23 | 2 | 20301699 | ||
| Pubmed | Expression of p300 and CBP is associated with poor prognosis in small cell lung cancer. | 4.18e-07 | 2 | 23 | 2 | 24551300 | |
| Pubmed | 4.18e-07 | 2 | 23 | 2 | 28967912 | ||
| Pubmed | CBP Is Required for Establishing Adaptive Gene Programs in the Adult Mouse Brain. | 4.18e-07 | 2 | 23 | 2 | 36109165 | |
| Pubmed | 4.18e-07 | 2 | 23 | 2 | 24639469 | ||
| Pubmed | 4.18e-07 | 2 | 23 | 2 | 37816914 | ||
| Pubmed | The MLL3/4 H3K4 methyltransferase complex in establishing an active enhancer landscape. | 4.18e-07 | 2 | 23 | 2 | 34156443 | |
| Pubmed | 4.18e-07 | 2 | 23 | 2 | 12242694 | ||
| Pubmed | 4.18e-07 | 2 | 23 | 2 | 33911074 | ||
| Pubmed | 4.18e-07 | 2 | 23 | 2 | 9018065 | ||
| Pubmed | 4.18e-07 | 2 | 23 | 2 | 24648406 | ||
| Pubmed | 4.18e-07 | 2 | 23 | 2 | 30135524 | ||
| Pubmed | Binding of p300/CBP co-activators by polyoma large T antigen. | 4.18e-07 | 2 | 23 | 2 | 11438528 | |
| Pubmed | 4.18e-07 | 2 | 23 | 2 | 10918613 | ||
| Pubmed | 4.18e-07 | 2 | 23 | 2 | 31182547 | ||
| Pubmed | 4.18e-07 | 2 | 23 | 2 | 35502657 | ||
| Pubmed | 4.18e-07 | 2 | 23 | 2 | 39287984 | ||
| Pubmed | 4.18e-07 | 2 | 23 | 2 | 30635043 | ||
| Pubmed | 4.18e-07 | 2 | 23 | 2 | 31898871 | ||
| Pubmed | Distribution of co-activators CBP and p300 during mouse oocyte and embryo development. | 4.18e-07 | 2 | 23 | 2 | 16596650 | |
| Pubmed | Phenotype and genotype in 52 patients with Rubinstein-Taybi syndrome caused by EP300 mutations. | 4.18e-07 | 2 | 23 | 2 | 27648933 | |
| Pubmed | Germline or inducible knockout of p300 or CBP in skeletal muscle does not alter insulin sensitivity. | 4.18e-07 | 2 | 23 | 2 | 30888860 | |
| Pubmed | Exploitation of EP300 and CREBBP Lysine Acetyltransferases by Cancer. | 4.18e-07 | 2 | 23 | 2 | 27881443 | |
| Pubmed | The p300 and CBP Transcriptional Coactivators Are Required for β-Cell and α-Cell Proliferation. | 4.18e-07 | 2 | 23 | 2 | 29217654 | |
| Pubmed | 4.18e-07 | 2 | 23 | 2 | 19272189 | ||
| Pubmed | 4.18e-07 | 2 | 23 | 2 | 10610021 | ||
| Pubmed | Emerging roles of p300/CBP in autophagy and autophagy-related human disorders. | 4.18e-07 | 2 | 23 | 2 | 37314181 | |
| Pubmed | 4.18e-07 | 2 | 23 | 2 | 20717166 | ||
| Pubmed | Distinct roles for CREB-binding protein and p300 in hematopoietic stem cell self-renewal. | 4.18e-07 | 2 | 23 | 2 | 12397173 | |
| Pubmed | 4.18e-07 | 2 | 23 | 2 | 10049825 | ||
| Pubmed | CBP/p300 TAZ1 domain forms a structured scaffold for ligand binding. | 4.18e-07 | 2 | 23 | 2 | 15641773 | |
| Pubmed | Differential contribution of p300 and CBP to regulatory element acetylation in mESCs. | 4.18e-07 | 2 | 23 | 2 | 32690000 | |
| Pubmed | 4.18e-07 | 2 | 23 | 2 | 9733868 | ||
| Pubmed | 4.18e-07 | 2 | 23 | 2 | 30953353 | ||
| Pubmed | 4.18e-07 | 2 | 23 | 2 | 21803292 | ||
| Pubmed | 4.18e-07 | 2 | 23 | 2 | 9811832 | ||
| Pubmed | 4.18e-07 | 2 | 23 | 2 | 25346535 | ||
| Pubmed | CBP/p300 acetyltransferase activity in hematologic malignancies. | 4.18e-07 | 2 | 23 | 2 | 27380996 | |
| Pubmed | CREBBP and p300 lysine acetyl transferases in the DNA damage response. | 4.18e-07 | 2 | 23 | 2 | 29170789 | |
| Pubmed | 4.18e-07 | 2 | 23 | 2 | 24089570 | ||
| Pubmed | 4.18e-07 | 2 | 23 | 2 | 25893291 | ||
| Pubmed | 4.18e-07 | 2 | 23 | 2 | 11559821 | ||
| Pubmed | 4.18e-07 | 2 | 23 | 2 | 21555743 | ||
| Pubmed | Rubinstein-Taybi syndrome in Chinese population with four novel mutations. | 4.18e-07 | 2 | 23 | 2 | 33063428 | |
| Pubmed | CBP/p300 induction is required for retinoic acid sensitivity in human mammary cells. | 4.18e-07 | 2 | 23 | 2 | 12646247 | |
| Pubmed | A ketogenic diet rescues hippocampal memory defects in a mouse model of Kabuki syndrome. | 4.18e-07 | 2 | 23 | 2 | 27999180 | |
| Pubmed | 4.18e-07 | 2 | 23 | 2 | 34506759 | ||
| Pubmed | 4.18e-07 | 2 | 23 | 2 | 31924266 | ||
| Pubmed | 4.18e-07 | 2 | 23 | 2 | 22177454 | ||
| Pubmed | 4.18e-07 | 2 | 23 | 2 | 15706485 | ||
| Pubmed | 4.18e-07 | 2 | 23 | 2 | 32576962 | ||
| Pubmed | 4.18e-07 | 2 | 23 | 2 | 27280393 | ||
| Pubmed | 4.18e-07 | 2 | 23 | 2 | 19822209 | ||
| Pubmed | AR coactivators, CBP/p300, are critical mediators of DNA repair in prostate cancer. | 4.18e-07 | 2 | 23 | 2 | 39266679 | |
| Pubmed | 4.18e-07 | 2 | 23 | 2 | 24522976 | ||
| Pubmed | 4.18e-07 | 2 | 23 | 2 | 22303793 | ||
| Pubmed | 4.18e-07 | 2 | 23 | 2 | 11867645 | ||
| Pubmed | CBP is required for environmental enrichment-induced neurogenesis and cognitive enhancement. | 4.18e-07 | 2 | 23 | 2 | 21847097 | |
| Pubmed | 4.18e-07 | 2 | 23 | 2 | 34732714 | ||
| Pubmed | Targeting histone acetylation dynamics and oncogenic transcription by catalytic P300/CBP inhibition. | 4.18e-07 | 2 | 23 | 2 | 34019788 | |
| Pubmed | 4.18e-07 | 2 | 23 | 2 | 36601880 | ||
| Pubmed | 5.96e-07 | 486 | 23 | 6 | 20936779 | ||
| Pubmed | 1.25e-06 | 3 | 23 | 2 | 15598887 | ||
| Pubmed | Dendrite development regulated by CREST, a calcium-regulated transcriptional activator. | 1.25e-06 | 3 | 23 | 2 | 14716005 | |
| Pubmed | The acetate/ACSS2 switch regulates HIF-2 stress signaling in the tumor cell microenvironment. | 1.25e-06 | 3 | 23 | 2 | 25689462 | |
| Pubmed | 1.25e-06 | 3 | 23 | 2 | 34463256 | ||
| Pubmed | 1.25e-06 | 3 | 23 | 2 | 18070920 | ||
| Pubmed | 1.25e-06 | 3 | 23 | 2 | 11973335 | ||
| Pubmed | The acetylation of transcription factor HBP1 by p300/CBP enhances p16INK4A expression. | 1.25e-06 | 3 | 23 | 2 | 21967847 | |
| Pubmed | 1.25e-06 | 3 | 23 | 2 | 9194564 | ||
| Pubmed | 1.25e-06 | 3 | 23 | 2 | 15171256 | ||
| Pubmed | p300/CBP acts as a coactivator of the cone-rod homeobox transcription factor. | 1.25e-06 | 3 | 23 | 2 | 10708567 | |
| Pubmed | 1.25e-06 | 3 | 23 | 2 | 16428436 | ||
| Pubmed | 1.25e-06 | 3 | 23 | 2 | 22523253 | ||
| Pubmed | Mutual synergistic folding in recruitment of CBP/p300 by p160 nuclear receptor coactivators. | 1.25e-06 | 3 | 23 | 2 | 11823864 | |
| Pubmed | CBP and p300 are essential for renin cell identity and morphological integrity of the kidney. | 1.25e-06 | 3 | 23 | 2 | 19252086 | |
| Pubmed | An essential role for p300/CBP in the cellular response to hypoxia. | 1.25e-06 | 3 | 23 | 2 | 8917528 | |
| Pubmed | Mutations of PTCH1, MLL2, and MLL3 are not frequent events in hepatoblastoma. | 1.25e-06 | 3 | 23 | 2 | 22183980 | |
| Pubmed | 1.25e-06 | 3 | 23 | 2 | 19948376 | ||
| Pubmed | E2A and CBP/p300 act in synergy to promote chromatin accessibility of the immunoglobulin κ locus. | 1.25e-06 | 3 | 23 | 2 | 22544934 | |
| Pubmed | 1.25e-06 | 3 | 23 | 2 | 27903646 | ||
| Pubmed | Gene dose-dependent control of hematopoiesis and hematologic tumor suppression by CBP. | 1.25e-06 | 3 | 23 | 2 | 10673499 | |
| Pubmed | 1.25e-06 | 3 | 23 | 2 | 12748286 | ||
| Pubmed | 1.25e-06 | 3 | 23 | 2 | 10347196 | ||
| Interaction | LATS1 interactions | 2.01e-07 | 440 | 21 | 7 | int:LATS1 | |
| Interaction | KLF2 interactions | 4.40e-07 | 15 | 21 | 3 | int:KLF2 | |
| Interaction | YAP1 interactions | 6.48e-07 | 1095 | 21 | 9 | int:YAP1 | |
| Interaction | GCM1 interactions | 6.79e-07 | 68 | 21 | 4 | int:GCM1 | |
| Interaction | HNF1A interactions | 1.31e-06 | 80 | 21 | 4 | int:HNF1A | |
| Interaction | MYOD1 interactions | 1.41e-06 | 194 | 21 | 5 | int:MYOD1 | |
| Interaction | SOX7 interactions | 1.45e-06 | 82 | 21 | 4 | int:SOX7 | |
| Interaction | KLF5 interactions | 1.45e-06 | 195 | 21 | 5 | int:KLF5 | |
| Interaction | FEV interactions | 1.76e-06 | 203 | 21 | 5 | int:FEV | |
| Interaction | GSC interactions | 1.83e-06 | 87 | 21 | 4 | int:GSC | |
| Interaction | STAT6 interactions | 1.83e-06 | 87 | 21 | 4 | int:STAT6 | |
| Interaction | FOXI1 interactions | 2.29e-06 | 92 | 21 | 4 | int:FOXI1 | |
| Interaction | SOX9 interactions | 2.83e-06 | 97 | 21 | 4 | int:SOX9 | |
| Interaction | KRT18 interactions | 3.25e-06 | 419 | 21 | 6 | int:KRT18 | |
| Interaction | TP53BP2 interactions | 4.08e-06 | 241 | 21 | 5 | int:TP53BP2 | |
| Interaction | PAX8 interactions | 4.85e-06 | 111 | 21 | 4 | int:PAX8 | |
| Interaction | TBXT interactions | 5.78e-06 | 116 | 21 | 4 | int:TBXT | |
| Interaction | E2F5 interactions | 6.81e-06 | 36 | 21 | 3 | int:E2F5 | |
| Interaction | HOXB2 interactions | 6.81e-06 | 36 | 21 | 3 | int:HOXB2 | |
| Interaction | ETS1 interactions | 6.84e-06 | 121 | 21 | 4 | int:ETS1 | |
| Interaction | EEF1B2 interactions | 6.85e-06 | 268 | 21 | 5 | int:EEF1B2 | |
| Interaction | PAX7 interactions | 7.54e-06 | 124 | 21 | 4 | int:PAX7 | |
| Interaction | HNF4A interactions | 7.76e-06 | 275 | 21 | 5 | int:HNF4A | |
| Interaction | KLF15 interactions | 1.00e-05 | 290 | 21 | 5 | int:KLF15 | |
| Interaction | MAPRE1 interactions | 1.05e-05 | 514 | 21 | 6 | int:MAPRE1 | |
| Interaction | PPARG interactions | 1.32e-05 | 307 | 21 | 5 | int:PPARG | |
| Interaction | NCOA6 interactions | 1.40e-05 | 145 | 21 | 4 | int:NCOA6 | |
| Interaction | H3C14 interactions | 1.87e-05 | 156 | 21 | 4 | int:H3C14 | |
| Interaction | KLF4 interactions | 2.06e-05 | 160 | 21 | 4 | int:KLF4 | |
| Interaction | TP73 interactions | 2.56e-05 | 169 | 21 | 4 | int:TP73 | |
| Interaction | KMT2D interactions | 2.56e-05 | 169 | 21 | 4 | int:KMT2D | |
| Interaction | SETD1A interactions | 2.61e-05 | 170 | 21 | 4 | int:SETD1A | |
| Interaction | EGR2 interactions | 2.68e-05 | 171 | 21 | 4 | int:EGR2 | |
| Interaction | NIN interactions | 2.81e-05 | 359 | 21 | 5 | int:NIN | |
| Interaction | TLX1 interactions | 2.93e-05 | 175 | 21 | 4 | int:TLX1 | |
| Interaction | TEAD1 interactions | 3.00e-05 | 176 | 21 | 4 | int:TEAD1 | |
| Interaction | USP7 interactions | 3.01e-05 | 1313 | 21 | 8 | int:USP7 | |
| Interaction | KDM1A interactions | 3.09e-05 | 941 | 21 | 7 | int:KDM1A | |
| Interaction | CEP63 interactions | 3.20e-05 | 179 | 21 | 4 | int:CEP63 | |
| Interaction | HOXB3 interactions | 3.71e-05 | 9 | 21 | 2 | int:HOXB3 | |
| Interaction | ARGFX interactions | 3.71e-05 | 9 | 21 | 2 | int:ARGFX | |
| Interaction | ATN1 interactions | 3.80e-05 | 187 | 21 | 4 | int:ATN1 | |
| Interaction | SMAD2 interactions | 3.92e-05 | 385 | 21 | 5 | int:SMAD2 | |
| Interaction | HNF1B interactions | 4.04e-05 | 190 | 21 | 4 | int:HNF1B | |
| Interaction | FAM120C interactions | 4.12e-05 | 191 | 21 | 4 | int:FAM120C | |
| Interaction | BMI1 interactions | 4.26e-05 | 659 | 21 | 6 | int:BMI1 | |
| Interaction | AR interactions | 4.34e-05 | 992 | 21 | 7 | int:AR | |
| Interaction | GATA2 interactions | 4.84e-05 | 199 | 21 | 4 | int:GATA2 | |
| Interaction | ETV4 interactions | 4.89e-05 | 69 | 21 | 3 | int:ETV4 | |
| Interaction | PRPH interactions | 5.33e-05 | 204 | 21 | 4 | int:PRPH | |
| Interaction | FAM184A interactions | 5.55e-05 | 72 | 21 | 3 | int:FAM184A | |
| Interaction | EGR1 interactions | 5.55e-05 | 72 | 21 | 3 | int:EGR1 | |
| Interaction | ILDR1 interactions | 5.66e-05 | 11 | 21 | 2 | int:ILDR1 | |
| Interaction | MINDY4 interactions | 5.79e-05 | 73 | 21 | 3 | int:MINDY4 | |
| Interaction | WWTR1 interactions | 6.06e-05 | 422 | 21 | 5 | int:WWTR1 | |
| Interaction | E2F3 interactions | 7.33e-05 | 79 | 21 | 3 | int:E2F3 | |
| Interaction | ERG interactions | 7.53e-05 | 223 | 21 | 4 | int:ERG | |
| Interaction | ABI1 interactions | 7.53e-05 | 223 | 21 | 4 | int:ABI1 | |
| Interaction | ASCL2 interactions | 8.01e-05 | 13 | 21 | 2 | int:ASCL2 | |
| Interaction | H3-4 interactions | 8.05e-05 | 448 | 21 | 5 | int:H3-4 | |
| Interaction | CDK12 interactions | 8.21e-05 | 228 | 21 | 4 | int:CDK12 | |
| Interaction | HDAC1 interactions | 8.76e-05 | 1108 | 21 | 7 | int:HDAC1 | |
| Interaction | NFE2 interactions | 8.80e-05 | 84 | 21 | 3 | int:NFE2 | |
| Interaction | NINL interactions | 8.93e-05 | 458 | 21 | 5 | int:NINL | |
| Interaction | IRF4 interactions | 9.12e-05 | 85 | 21 | 3 | int:IRF4 | |
| Interaction | CDX2 interactions | 9.44e-05 | 86 | 21 | 3 | int:CDX2 | |
| Interaction | CDH1 interactions | 9.97e-05 | 768 | 21 | 6 | int:CDH1 | |
| Interaction | N4BP2 interactions | 1.05e-04 | 89 | 21 | 3 | int:N4BP2 | |
| Interaction | SMAD1 interactions | 1.05e-04 | 243 | 21 | 4 | int:SMAD1 | |
| Interaction | PRRG1 interactions | 1.08e-04 | 15 | 21 | 2 | int:PRRG1 | |
| Interaction | MGMT interactions | 1.15e-04 | 92 | 21 | 3 | int:MGMT | |
| Interaction | CDC27 interactions | 1.15e-04 | 249 | 21 | 4 | int:CDC27 | |
| Interaction | ATG16L1 interactions | 1.18e-04 | 1161 | 21 | 7 | int:ATG16L1 | |
| Interaction | CRX interactions | 1.25e-04 | 254 | 21 | 4 | int:CRX | |
| Interaction | MAML2 interactions | 1.39e-04 | 17 | 21 | 2 | int:MAML2 | |
| Interaction | H2AC4 interactions | 1.43e-04 | 506 | 21 | 5 | int:H2AC4 | |
| Interaction | ASH2L interactions | 1.47e-04 | 265 | 21 | 4 | int:ASH2L | |
| Interaction | ING1 interactions | 1.61e-04 | 103 | 21 | 3 | int:ING1 | |
| Interaction | U2AF1L4 interactions | 1.75e-04 | 19 | 21 | 2 | int:U2AF1L4 | |
| Interaction | NEUROG1 interactions | 1.75e-04 | 19 | 21 | 2 | int:NEUROG1 | |
| Interaction | CEBPA interactions | 1.82e-04 | 1245 | 21 | 7 | int:CEBPA | |
| Interaction | KRT19 interactions | 1.86e-04 | 282 | 21 | 4 | int:KRT19 | |
| Interaction | SPIB interactions | 1.94e-04 | 20 | 21 | 2 | int:SPIB | |
| Interaction | EN1 interactions | 1.96e-04 | 110 | 21 | 3 | int:EN1 | |
| Interaction | RBBP5 interactions | 1.99e-04 | 287 | 21 | 4 | int:RBBP5 | |
| Interaction | TBR1 interactions | 2.12e-04 | 113 | 21 | 3 | int:TBR1 | |
| Interaction | HOXB4 interactions | 2.15e-04 | 21 | 21 | 2 | int:HOXB4 | |
| Interaction | PLAGL1 interactions | 2.15e-04 | 21 | 21 | 2 | int:PLAGL1 | |
| Interaction | KLF13 interactions | 2.15e-04 | 21 | 21 | 2 | int:KLF13 | |
| Interaction | CITED4 interactions | 2.15e-04 | 21 | 21 | 2 | int:CITED4 | |
| Interaction | TFAP2A interactions | 2.18e-04 | 114 | 21 | 3 | int:TFAP2A | |
| Interaction | UBE2D1 interactions | 2.18e-04 | 294 | 21 | 4 | int:UBE2D1 | |
| Interaction | PAPPA interactions | 2.36e-04 | 22 | 21 | 2 | int:PAPPA | |
| Interaction | SP7 interactions | 2.48e-04 | 304 | 21 | 4 | int:SP7 | |
| Interaction | DDIT3 interactions | 2.53e-04 | 120 | 21 | 3 | int:DDIT3 | |
| Interaction | CITED2 interactions | 2.58e-04 | 23 | 21 | 2 | int:CITED2 | |
| Interaction | HOXD10 interactions | 2.58e-04 | 23 | 21 | 2 | int:HOXD10 | |
| Interaction | UTY interactions | 2.58e-04 | 23 | 21 | 2 | int:UTY | |
| Interaction | FOS interactions | 2.74e-04 | 312 | 21 | 4 | int:FOS | |
| Interaction | NDC80 interactions | 2.74e-04 | 312 | 21 | 4 | int:NDC80 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 8.67e-05 | 17 | 15 | 2 | 486 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 9.75e-05 | 18 | 15 | 2 | 91 | |
| GeneFamily | Ataxins|Trinucleotide repeat containing | 1.91e-04 | 25 | 15 | 2 | 775 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 3.55e-04 | 34 | 15 | 2 | 487 | |
| GeneFamily | PHD finger proteins | 2.47e-03 | 90 | 15 | 2 | 88 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | 1.55e-06 | 1492 | 22 | 9 | M40023 | |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 1.43e-05 | 180 | 22 | 4 | M8239 | |
| Coexpression | GSE21927_C26GM_VS_4T1_TUMOR_MONOCYTE_BALBC_DN | 2.12e-05 | 199 | 22 | 4 | M7607 | |
| Coexpression | GSE24671_CTRL_VS_BAKIMULC_INFECTED_MOUSE_SPLENOCYTES_DN | 3.77e-04 | 170 | 22 | 3 | M9445 | |
| Coexpression | GSE15271_CXCR4_POS_VS_NEG_GC_BCELL_DN | 4.10e-04 | 175 | 22 | 3 | M7101 | |
| Coexpression | GSE3720_UNSTIM_VS_PMA_STIM_VD2_GAMMADELTA_TCELL_UP | 4.10e-04 | 175 | 22 | 3 | M6340 | |
| Coexpression | GSE13547_CTRL_VS_ANTI_IGM_STIM_BCELL_12H_DN | 4.31e-04 | 178 | 22 | 3 | M2980 | |
| Coexpression | GSE35825_UNTREATED_VS_IFNG_STIM_MACROPHAGE_DN | 4.53e-04 | 181 | 22 | 3 | M8662 | |
| Coexpression | GSE27291_0H_VS_7D_STIM_GAMMADELTA_TCELL_DN | 5.22e-04 | 190 | 22 | 3 | M8457 | |
| Coexpression | GSE46606_IRF4_KO_VS_WT_CD40L_IL2_IL5_3DAY_STIMULATED_BCELL_DN | 5.63e-04 | 195 | 22 | 3 | M9824 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | 5.64e-04 | 467 | 22 | 4 | M1347 | |
| Coexpression | GSE45365_CD8A_DC_VS_CD11B_DC_IFNAR_KO_DN | 5.71e-04 | 196 | 22 | 3 | M10002 | |
| Coexpression | GSE21927_SPLENIC_VS_TUMOR_MONOCYTES_FROM_C26GM_TUMOROUS_MICE_BALBC_DN | 5.88e-04 | 198 | 22 | 3 | M7605 | |
| Coexpression | GSE3039_ALPHABETA_CD8_TCELL_VS_B2_BCELL_UP | 5.97e-04 | 199 | 22 | 3 | M6443 | |
| Coexpression | GSE21927_SPLEEN_C57BL6_VS_EL4_TUMOR_BALBC_MONOCYTES_UP | 5.97e-04 | 199 | 22 | 3 | M7596 | |
| Coexpression | CUI_TCF21_TARGETS_2_DN | 6.02e-04 | 854 | 22 | 5 | M1533 | |
| Coexpression | GSE31082_DN_VS_CD8_SP_THYMOCYTE_DN | 6.06e-04 | 200 | 22 | 3 | M5063 | |
| Coexpression | GSE41867_DAY8_VS_DAY15_LCMV_CLONE13_EFFECTOR_CD8_TCELL_UP | 6.06e-04 | 200 | 22 | 3 | M9449 | |
| Coexpression | GSE26669_CTRL_VS_COSTIM_BLOCK_MLR_CD8_TCELL_DN | 6.06e-04 | 200 | 22 | 3 | M4667 | |
| Coexpression | GSE17186_NAIVE_VS_CD21LOW_TRANSITIONAL_BCELL_CORD_BLOOD_UP | 6.06e-04 | 200 | 22 | 3 | M7175 | |
| Coexpression | GSE3920_UNTREATED_VS_IFNA_TREATED_FIBROBLAST_DN | 6.06e-04 | 200 | 22 | 3 | M6687 | |
| Coexpression | GSE27786_LIN_NEG_VS_NKTCELL_DN | 6.06e-04 | 200 | 22 | 3 | M4788 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | 6.09e-04 | 856 | 22 | 5 | M4500 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | 6.45e-04 | 484 | 22 | 4 | MM999 | |
| Coexpression | SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_DN | 6.51e-04 | 45 | 22 | 2 | M8813 | |
| Coexpression | VANTVEER_BREAST_CANCER_METASTASIS_UP | 6.51e-04 | 45 | 22 | 2 | M500 | |
| Coexpression | KRASNOSELSKAYA_ILF3_TARGETS_DN | 6.81e-04 | 46 | 22 | 2 | M12166 | |
| Coexpression | CUI_TCF21_TARGETS_2_DN | 7.19e-04 | 888 | 22 | 5 | MM1018 | |
| Coexpression | ASTON_MAJOR_DEPRESSIVE_DISORDER_UP | 7.72e-04 | 49 | 22 | 2 | M25 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.72e-07 | 127 | 22 | 5 | gudmap_developingGonad_e16.5_epididymis_1000_k4 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#3_top-relative-expression-ranked_1000 | 7.72e-06 | 275 | 22 | 5 | gudmap_developingGonad_e14.5_ epididymis_1000_k3 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000 | 1.00e-05 | 790 | 22 | 7 | gudmap_developingGonad_e16.5_epididymis_1000 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_1000 | 1.24e-04 | 799 | 22 | 6 | gudmap_developingGonad_e18.5_epididymis_1000 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000 | 1.26e-04 | 801 | 22 | 6 | gudmap_developingGonad_e14.5_ epididymis_1000 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.33e-04 | 259 | 22 | 4 | gudmap_developingGonad_e12.5_epididymis_k3_1000 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.82e-04 | 281 | 22 | 4 | gudmap_developingGonad_e18.5_epididymis_1000_k3 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_k-means-cluster#1_top-relative-expression-ranked_1000 | 4.11e-04 | 142 | 22 | 3 | gudmap_developingKidney_e15.5_1000_k1 | |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_k-means-cluster#5_top-relative-expression-ranked_1000 | 4.92e-04 | 151 | 22 | 3 | gudmap_developingGonad_P2_ovary_1000_k5 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 3.62e-08 | 186 | 23 | 5 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.62e-06 | 191 | 23 | 4 | 7d1595e616f6f111fc2f5bc1b179c5d67d624cc9 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.14e-06 | 200 | 23 | 4 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4-Trm_Th1/Th17|bone_marrow / Manually curated celltypes from each tissue | 7.84e-05 | 163 | 23 | 3 | 4d1fd0b1246833723b938eca0cb246e937380e12 | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.84e-05 | 176 | 23 | 3 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-04 | 182 | 23 | 3 | f8c73baaaca145e2efc48f10f636feb79c8fc779 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-04 | 184 | 23 | 3 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.14e-04 | 185 | 23 | 3 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.14e-04 | 185 | 23 | 3 | 98b8ee42b89d97e4c9db01740e0c193503c68f2c | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 1.27e-04 | 192 | 23 | 3 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.31e-04 | 194 | 23 | 3 | a44be2f021cfdd0fcdc698c3f04d66db7a1aa6c2 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.33e-04 | 195 | 23 | 3 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.33e-04 | 195 | 23 | 3 | 2e1df01bf6e4e98e6cd9fb50926e34c5077b8666 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.33e-04 | 195 | 23 | 3 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid|BALF-PFMC / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.35e-04 | 196 | 23 | 3 | 6361c37b0292ba9e5bf485a4809d2b0cd894c26e | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.37e-04 | 197 | 23 | 3 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | systemic_lupus_erythematosus-treated|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.39e-04 | 198 | 23 | 3 | 8165ff735095c52994fb5057d89be93cc378b7da | |
| ToppCell | systemic_lupus_erythematosus-flare|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.39e-04 | 198 | 23 | 3 | 4c93ee921d56132d80832d8e94563f32ccf13bbc | |
| ToppCell | PBMC_fresh-frozen|World / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.39e-04 | 198 | 23 | 3 | dcc223a0396b8b673e4ed8c6733ec6cd74e9a03a | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.39e-04 | 198 | 23 | 3 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.39e-04 | 198 | 23 | 3 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.39e-04 | 198 | 23 | 3 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.41e-04 | 199 | 23 | 3 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 1.41e-04 | 199 | 23 | 3 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.44e-04 | 200 | 23 | 3 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| Drug | 3,4-dimethoxy-N-((2,2-dimethyl-2H-chromen-6-yl)methyl)-N-phenylbenzenesulfonamide | 8.90e-06 | 5 | 22 | 2 | ctd:C575894 | |
| Disease | Menke-Hennekam syndrome | 5.31e-07 | 2 | 22 | 2 | cv:C5681632 | |
| Disease | Rubinstein-Taybi syndrome (implicated_via_orthology) | 5.31e-07 | 2 | 22 | 2 | DOID:1933 (implicated_via_orthology) | |
| Disease | Rubinstein-Taybi syndrome | 5.31e-07 | 2 | 22 | 2 | cv:C0035934 | |
| Disease | Kleefstra syndrome 2 (implicated_via_orthology) | 5.31e-07 | 2 | 22 | 2 | DOID:0080598 (implicated_via_orthology) | |
| Disease | RUBINSTEIN-TAYBI SYNDROME 1 | 5.31e-07 | 2 | 22 | 2 | C4551859 | |
| Disease | Rubinstein-Taybi syndrome (is_implicated_in) | 5.31e-07 | 2 | 22 | 2 | DOID:1933 (is_implicated_in) | |
| Disease | RUBINSTEIN-TAYBI SYNDROME 1 | 5.31e-07 | 2 | 22 | 2 | 180849 | |
| Disease | Rubinstein-Taybi syndrome due to CREBBP mutations | 5.31e-07 | 2 | 22 | 2 | cv:C4551859 | |
| Disease | Rubinstein-Taybi Syndrome | 5.31e-07 | 2 | 22 | 2 | C0035934 | |
| Disease | Squamous cell carcinoma of esophagus | 7.05e-07 | 95 | 22 | 4 | C0279626 | |
| Disease | Adenoid Cystic Carcinoma | 8.67e-07 | 100 | 22 | 4 | C0010606 | |
| Disease | Sezary Syndrome | 1.04e-06 | 27 | 22 | 3 | C0036920 | |
| Disease | Bladder Neoplasm | 3.32e-06 | 140 | 22 | 4 | C0005695 | |
| Disease | Malignant neoplasm of urinary bladder | 3.42e-06 | 141 | 22 | 4 | C0005684 | |
| Disease | Carcinoma, Transitional Cell | 3.76e-06 | 41 | 22 | 3 | C0007138 | |
| Disease | prostate cancer (is_marker_for) | 5.11e-06 | 156 | 22 | 4 | DOID:10283 (is_marker_for) | |
| Disease | Diffuse Large B-Cell Lymphoma | 9.20e-06 | 55 | 22 | 3 | C0079744 | |
| Disease | Lymphoma, Large-Cell, Follicular | 5.54e-05 | 15 | 22 | 2 | C0079745 | |
| Disease | Lymphoma, Small Cleaved-Cell, Follicular | 5.54e-05 | 15 | 22 | 2 | C0079765 | |
| Disease | Lymphoma, Mixed-Cell, Follicular | 5.54e-05 | 15 | 22 | 2 | C0079758 | |
| Disease | Lymphoma, Follicular, Grade 2 | 5.54e-05 | 15 | 22 | 2 | C1956132 | |
| Disease | Lymphoma, Follicular, Grade 3 | 5.54e-05 | 15 | 22 | 2 | C1956131 | |
| Disease | Lymphoma, Follicular, Grade 1 | 5.54e-05 | 15 | 22 | 2 | C1956130 | |
| Disease | T-Cell Lymphoma | 6.33e-05 | 16 | 22 | 2 | C0079772 | |
| Disease | Prostatic Neoplasms | 7.65e-05 | 616 | 22 | 5 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 7.65e-05 | 616 | 22 | 5 | C0376358 | |
| Disease | Lymphoma, Follicular | 1.00e-04 | 20 | 22 | 2 | C0024301 | |
| Disease | congenital diaphragmatic hernia (biomarker_via_orthology) | 1.45e-04 | 24 | 22 | 2 | DOID:3827 (biomarker_via_orthology) | |
| Disease | lung small cell carcinoma (is_implicated_in) | 1.98e-04 | 28 | 22 | 2 | DOID:5409 (is_implicated_in) | |
| Disease | Toxic Epidermal Necrolysis | 2.13e-04 | 29 | 22 | 2 | C0014518 | |
| Disease | Mycoplasma-Induced Stevens-Johnson Syndrome | 2.13e-04 | 29 | 22 | 2 | C3658301 | |
| Disease | Stevens-Johnson Syndrome Toxic Epidermal Necrolysis Spectrum | 2.13e-04 | 29 | 22 | 2 | C3658302 | |
| Disease | Drug-Induced Stevens Johnson Syndrome | 2.13e-04 | 29 | 22 | 2 | C1274933 | |
| Disease | osteoarthritis, knee | 2.15e-04 | 158 | 22 | 3 | EFO_0004616 | |
| Disease | Stevens-Johnson Syndrome | 2.28e-04 | 30 | 22 | 2 | C0038325 | |
| Disease | Leukemia, Myelocytic, Acute | 2.81e-04 | 173 | 22 | 3 | C0023467 | |
| Disease | Alzheimer disease | 4.17e-04 | 485 | 22 | 4 | MONDO_0004975 | |
| Disease | oral microbiome measurement | 4.49e-04 | 42 | 22 | 2 | EFO_0801229 | |
| Disease | esophagus squamous cell carcinoma (is_implicated_in) | 5.15e-04 | 45 | 22 | 2 | DOID:3748 (is_implicated_in) | |
| Disease | schizophrenia, anorexia nervosa | 5.86e-04 | 48 | 22 | 2 | MONDO_0005090, MONDO_0005351 | |
| Disease | diverticular disease | 6.95e-04 | 236 | 22 | 3 | EFO_0009959 | |
| Disease | Small cell carcinoma of lung | 7.42e-04 | 54 | 22 | 2 | C0149925 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SQMIRDQQQQILQQN | 586 | Q96MC4 | |
| DILRRQQMMQQQQQQ | 2181 | Q09472 | |
| KEQRRLQQQLAQQMQ | 216 | O95319 | |
| QYQQRRQQENMQRQS | 276 | O15372 | |
| EMLRRQLLQQQQQQQ | 2191 | Q92793 | |
| ARQQQQIENQQQMLV | 136 | Q96KQ4 | |
| QERQEQQQQRQMQAM | 3061 | Q8NEZ4 | |
| QQQQRQMQAMIRQRS | 3066 | Q8NEZ4 | |
| QQMEQLNRRYQNIQR | 876 | Q76N89 | |
| TRQQNISMQRQENLR | 971 | Q15154 | |
| IQRRQVMEQHQQQRQ | 136 | Q9UI08 | |
| RNVQLMRQQQGQLQR | 826 | Q2M1P5 | |
| QQEQRQVEELRMQLQ | 536 | Q8IZQ8 | |
| QRILMNRRLQQQYNQ | 2406 | P46100 | |
| RQQRELMKALQQQQQ | 966 | Q6Y7W6 | |
| RQRQQQQQQQESLRA | 116 | A0A1B0GTI1 | |
| QMVQNENDNRVQRKQ | 41 | Q8NEH6 | |
| MERQQQQQQQLRNLR | 1 | Q9Y5J6 | |
| RYGRQRRRQQQQQQQ | 181 | B2RXF0 | |
| QQMRQLQLQNQELLR | 661 | Q5T5P2 | |
| QLREEQQRQQQQMEQ | 2666 | Q15149 | |
| QQRQQQQMEQERQRL | 2671 | Q15149 | |
| QRNQLQGAMQQFNQR | 426 | Q9H0M0 | |
| LQERQLQLQQQRMQL | 3716 | O14686 | |
| QRQRQQQQQQRRQQE | 86 | B1AL88 |